Skip to content
Research Article Open access CC BY 4.0

Performance of P2x7 and P2Y Purinergic Receptors as an Inhibiting Factor in the Progression of Pulmonary Neoplastic Cells

Matheus Ribeiro Bizuti, Laura Nyland Jostl, Emanuely Scramim, Keroli Eloiza Tessaro da Silva, Luana Paula Schio, Gabriela Vidotto Cavallieri, Renata Calciolari Rossi, Débora Tavares de Resende e Silva

Annual Research & Review in Biology · pp. 56–62 · Published 11 Dec 2020

10.9734/arrb/2020/v35i1230311

Abstract

Different pathological processes are considered in lung cancer, such as nicotine deposition, oxidative stress, deregulation of metal ions and chronic inflammation. Purine signaling is involved in all processes, suggesting the importance of nucleotide receptors (P2X7 and P2Y) and adenosine receptors present in lung cells. The accumulation of toxic substances promotes chronic inflammation and cellular alteration, which induces the release of Adenosine Triphosphate (ATP) in the extracellular space, thus stimulating P2X7 receptors. The activation of P2X7 promotes an increase in the synthesis and release of some pro-inflammatory mediators. P2Y works by promoting the increase of intracellular calcium levels and, P2X7, changing cell permeability. Thus, drugs can be developed with a specific targeting for such recipients, thus provid additional therapeutic options to those existing.

Adenosine triphosphate cell proliferation lung neoplasms tobacco use disorder purinergic signaling

References (24)

  1. 1 Global cancer statistics [DOI]
  2. 2 Global cancer statistics, 2012 [DOI]
  3. 3 Molecular Physiology of P2X Receptors [DOI]
  4. 4 A cytokine-mediated link between innate immunity, inflammation, and cancer [DOI]
  5. 5 Non-small cell lung cancer: current treatment and future advances [DOI]
  6. 6 Purine and pyrimidine receptors [DOI]
  7. 7 Progression and metastasis of lung cancer [DOI]
  8. 8 CD73 on Tumor Cells Impairs Antitumor T-Cell Responses: A Novel Mechanism of Tumor-Induced Immune Suppression [DOI]
  9. 9 Classification and Pathology of Lung Cancer [DOI]
  10. 10 Purinergic signalling and cancer [DOI]
  11. 11 Heme Oxygenase-1 in Tumor Biology and Therapy [DOI]
  12. 12 Familial risk for lung cancer [DOI]
  13. 13 P2X7 in Cancer: From Molecular Mechanisms to Therapeutics [DOI]
  14. 14 Exposure to secondhand tobacco smoke and lung cancer by histological type: A pooled analysis of the International Lung Cancer Consortium (ILCCO) [DOI]
  15. 15 Improving outcomes in lung cancer: the value of the multidisciplinary health care team [DOI]
  16. 16 Purinergic Signaling in the Hallmarks of Cancer [DOI]
  17. 17 Metformin Sensitizes Non-small Cell Lung Cancer Cells to an Epigallocatechin-3-Gallate (EGCG) Treatment by Suppressing the Nrf2/HO-1 Signaling Pathway [DOI]
  18. 18 P2 receptor interaction and signalling cascades in neuroprotection [DOI]
  19. 19 Emodin Inhibits ATP-Induced Proliferation and Migration by Suppressing P2Y Receptors in Human Lung Adenocarcinoma Cells [DOI]
  20. 20 Correlation of P2RX7 gene rs1718125 polymorphism with postoperative fentanyl analgesia in patients with lung cancer [DOI]
  21. 21 P2 receptors in renal pathophysiology [DOI]
  22. 22 Interaction of Zn with Losartan. Activation of Intrinsic Apoptotic Signaling Pathway in Lung Cancer Cells and Effects on Alkaline and Acid Phosphatases [DOI]
  23. 23 Hereditary Lung Cancer Risk: Recent Discoveries and Implications for Genetic Counseling and Testing [DOI]
  24. 24 [Effect and mechanism of silibinin on the inhibition of ALK positive NSCLC cells by sensitizing crizotinib]. [DOI]

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

17

Page views

0

PDF downloads

1

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.